Total Payments
$195,657
2024 Payments
$28,119
Companies
11
Transactions
184
Medicare Patients
284
Medicare Billing
$37,730
Payment Breakdown by Category
Consulting$112,001 (57.2%)
Other$53,858 (27.5%)
Travel$18,630 (9.5%)
Research$6,729 (3.4%)
Food & Beverage$4,440 (2.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $112,001 | 39 | 57.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $29,135 | 19 | 14.9% |
| Honoraria | $22,608 | 11 | 11.6% |
| Travel and Lodging | $18,630 | 46 | 9.5% |
| Unspecified | $6,729 | 5 | 3.4% |
| Food and Beverage | $4,440 | 63 | 2.3% |
| Compensation for serving as faculty or as a speaker for a medical education program | $2,115 | 1 | 1.1% |
Payments by Type
General
$188,928
179 transactions
Research
$6,729
5 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $62,257 | 34 | $0 (2020) |
| PFIZER INC. | $51,571 | 43 | $0 (2024) |
| Global Blood Therapeutics, Inc. | $33,509 | 28 | $0 (2022) |
| Agios Pharmaceuticals, Inc. | $27,260 | 52 | $0 (2024) |
| Emmaus Medical, Inc. | $6,676 | 12 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $5,023 | 7 | $0 (2022) |
| Ortho-Clinical Diagnostics, Inc. | $3,300 | 1 | $0 (2023) |
| Novartis Pharma AG | $1,925 | 1 | $0 (2020) |
| CSL Behring | $1,640 | 1 | $0 (2020) |
| VERTEX PHARMACEUTICALS INCORPORATED | $1,596 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28,119 | 39 | PFIZER INC. ($14,769) |
| 2023 | $18,555 | 23 | PFIZER INC. ($13,140) |
| 2022 | $32,459 | 40 | Agios Pharmaceuticals, Inc. ($12,890) |
| 2021 | $14,476 | 9 | Global Blood Therapeutics, Inc. ($14,476) |
| 2020 | $16,379 | 19 | Global Blood Therapeutics, Inc. ($6,750) |
| 2019 | $40,504 | 21 | Novartis Pharmaceuticals Corporation ($39,636) |
| 2018 | $26,696 | 16 | Novartis Pharmaceuticals Corporation ($12,022) |
| 2017 | $18,468 | 17 | Novartis Pharmaceuticals Corporation ($8,844) |
All Payment Transactions
184 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Consulting Fee | Cash or cash equivalent | $1,110.00 | General |
| Category: Genetically Defined Disease | ||||||
| 12/07/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $42.93 | General |
| Category: Genetically Defined Disease | ||||||
| 12/07/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Travel and Lodging | Cash or cash equivalent | $19.85 | General |
| Category: Genetically Defined Disease | ||||||
| 12/07/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $5.42 | General |
| Category: Genetically Defined Disease | ||||||
| 12/06/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $36.15 | General |
| Category: Genetically Defined Disease | ||||||
| 11/25/2024 | PFIZER INC. | VYNDAMAX (Drug) | Consulting Fee | Cash or cash equivalent | $3,255.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/14/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $2,092.50 | General |
| 10/31/2024 | PFIZER INC. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $780.00 | General |
| Category: HEMATOLOGY | ||||||
| 10/31/2024 | PFIZER INC. | OXBRYTA (Drug) | Travel and Lodging | In-kind items and services | $133.64 | General |
| Category: HEMATOLOGY | ||||||
| 10/31/2024 | PFIZER INC. | OXBRYTA (Drug) | Travel and Lodging | In-kind items and services | $16.40 | General |
| Category: HEMATOLOGY | ||||||
| 10/30/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| 10/24/2024 | Agios Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $93.77 | General |
| 10/18/2024 | PFIZER INC. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,340.00 | General |
| Category: HEMATOLOGY | ||||||
| 10/02/2024 | PFIZER INC. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,875.00 | General |
| Category: HEMATOLOGY | ||||||
| 10/02/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $6.22 | General |
| Category: Genetically Defined Disease | ||||||
| 10/01/2024 | PFIZER INC. | OXBRYTA (Drug) | Travel and Lodging | In-kind items and services | $728.85 | General |
| Category: HEMATOLOGY | ||||||
| 10/01/2024 | PFIZER INC. | OXBRYTA (Drug) | Consulting Fee | Cash or cash equivalent | $465.00 | General |
| Category: HEMATOLOGY | ||||||
| 09/18/2024 | PFIZER INC. | OXBRYTA (Drug) | Travel and Lodging | In-kind items and services | $652.27 | General |
| Category: HEMATOLOGY | ||||||
| 09/18/2024 | PFIZER INC. | OXBRYTA (Drug) | Travel and Lodging | In-kind items and services | $227.67 | General |
| Category: HEMATOLOGY | ||||||
| 09/14/2024 | PFIZER INC. | OXBRYTA (Drug) | Travel and Lodging | In-kind items and services | $689.89 | General |
| Category: HEMATOLOGY | ||||||
| 09/03/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $135.22 | General |
| Category: Genetically Defined Disease | ||||||
| 07/23/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Travel and Lodging | Cash or cash equivalent | $18.75 | General |
| Category: Genetically Defined Disease | ||||||
| 07/23/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $5.69 | General |
| Category: Genetically Defined Disease | ||||||
| 05/22/2024 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $88.70 | General |
| Category: HEMATOLOGY | ||||||
| 05/20/2024 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $96.52 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RIVIPANSEL CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $3,200 | 1 |
| CSEG101A2301 | Novartis Pharma AG | $1,925 | 1 |
| RESEARCH RELATED PUBLICATIONS SUPPORT | NOVARTIS PHARMACEUTICALS CORPORATION | $1,604 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 31 | 63 | $25,344 | $6,425 |
| 2022 | 2 | 56 | 116 | $42,486 | $11,318 |
| 2021 | 5 | 89 | 175 | $43,475 | $10,232 |
| 2020 | 6 | 108 | 188 | $46,399 | $9,755 |
Total Patients
284
Total Services
542
Medicare Billing
$37,730
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 31 | 63 | $25,344 | $6,425 | 25.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 33 | 78 | $31,200 | $8,587 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 23 | 38 | $11,286 | $2,731 | 24.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 34 | 81 | $24,057 | $5,718 | 23.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 15 | 42 | $8,484 | $2,228 | 26.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 15 | 23 | $5,083 | $959.66 | 18.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 14 | 18 | $3,618 | $751.15 | 20.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 11 | 11 | $2,233 | $574.20 | 25.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 13 | 30 | $8,553 | $2,401 | 28.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 25 | 42 | $12,213 | $2,229 | 18.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 17 | 30 | $5,958 | $1,699 | 28.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 24 | 43 | $8,463 | $1,332 | 15.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 12 | 19 | $5,999 | $1,129 | 18.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 17 | 24 | $5,213 | $965.70 | 18.5% |
About Dr. Wally Smith, M.D
Dr. Wally Smith, M.D is a Internal Medicine healthcare provider based in Richmond, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487743548.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wally Smith, M.D has received a total of $195,657 in payments from pharmaceutical and medical device companies, with $28,119 received in 2024. These payments were reported across 184 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($112,001).
As a Medicare-enrolled provider, Smith has provided services to 284 Medicare beneficiaries, totaling 542 services with total Medicare billing of $37,730. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Richmond, VA
- Active Since 10/12/2006
- Last Updated 02/28/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1487743548
Products in Payments
- OXBRYTA (Drug) $48,256
- ADAKVEO (Biological) $36,759
- PYRUKYND (Drug) $27,167
- CRIZANLIZUMAB (Biological) $11,966
- Endari (Drug) $6,676
- ORTHO (Device) $3,300
- VYNDAMAX (Drug) $3,255
- SEG101A_ADAKVEO_HEMATOLOGY (Biological) $1,925
- IW-1701 $900.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Richmond
Dr. George Vetrovec, M.d, M.D
Internal Medicine — Payments: $3.2M
Internal Medicine $3.2M
Dr. Arun Sanyal, M.d, M.D
Internal Medicine — Payments: $956,666
Internal Medicine $956,666
Dr. Erica Gregonis, Md, MD
Internal Medicine — Payments: $314,689
Internal Medicine $314,689
Dr. Lawrence Schwartz, M.d, M.D
Internal Medicine — Payments: $205,580
Internal Medicine $205,580
Dr. Gaurav Gupta, Md, MD
Internal Medicine — Payments: $189,406
Internal Medicine $189,406
Dr. Andrew Poklepovic, M.d, M.D
Internal Medicine — Payments: $112,763
Internal Medicine $112,763